DCF — BAILEY MEDICAL CENTER
Enterprise Value: $65.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$65.1M
Enterprise Value
$17.8M
PV of Cash Flows
$47.3M
PV of Terminal Value
$76.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $56.3M | $7.8M | 14.0% | $3.8M | $3.4M |
| Year 2 | $57.9M | $8.6M | 15.0% | $4.3M | $3.6M |
| Year 3 | $59.7M | $9.4M | 16.0% | $4.9M | $3.7M |
| Year 4 | $61.5M | $10.0M | 16.0% | $5.3M | $3.6M |
| Year 5 | $63.3M | $10.5M | 17.0% | $5.6M | $3.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $65.1M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$54.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1329662845094241
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5